Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management

FinSMEs

Orchard Therapeutics Prices Initial Public Offering

Stock markets Health Costs
$421,000,000 IPO
AVCJ

Innovent Biologics gains on debut after $421m IPO

$70,000,000 IPO
Xconomy

Twist Bioscience IPO Hauls In $70M for DNA Synthesis Technology

Earnings Funding Science
$200,000,000 IPO
PE Hub , FinSMEs

VC-backed Orchard Therapeutics goes public

Stock markets
$80,000,000 Venture capital (Series D)
FinSMEs , Xconomy

TP Therapeutics Completes $80M Mezzanine Financing

Funding Health
PE Hub

China's Innovent Biologics looks to raise up to $422 million in HK IPO, say sources: Reuters

$125,000,000 Venture capital (Series C)
FinSMEs

Atreca Raises $125M in Series C Funding

Funding
MedCity News

Atreca raises $125M in oversubscribed Series C funding round

$42,300,000 Venture capital (Series B)
FinSMEs , Xconomy , PE Hub

Renovia Completes $42.3M in Series B and Debt Financing

Funding Health
$150,000,000 Venture capital (Series C)
FinSMEs

Orchard Therapeutics Raises $150M in Series C Financing

Funding Health
Xconomy

FDA Puts Mersana Cancer Study on Partial Hold After Patient Death

Health
$60,000,000 IPO
PE Hub

VC-backed Constellation Pharmaceuticals rolls out IPO

Stock markets Funding Health
$70,000,000 Venture capital (Series C)
Xconomy , FinSMEs

Cibus Raises $70M for Marketing of Gene-Edited Canola, More R&D

Funding
$150,000,000 IPO
PE Hub

Autolus goes public

Stock markets Privacy
$75,000,000 IPO
PE Hub

VC-backed Kezar Life Sciences unveils IPO

Stock markets Health
$99,700,000 IPO
PE Hub

VC-backed Avrobio rolls out IPO

Stock markets Health
PE Hub

Autolus sets IPO pricing terms

Stock markets Privacy
PE Hub

Autolus taps Oakley as SVP and CFO

Xconomy

Rare Disease Biotechs Avrobio, Eidos Therapeutics File for IPOs

Health Science
Xconomy

Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined

Health Stock markets Science